img

Global Narcotic (Opioid) Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Narcotic (Opioid) Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Narcotics, also called opioids, are a necessary and important part of medical care. They include strong prescription pain relievers, such as oxycodone, hydrocodone, fentanyl, and tramadol. The illegal drug heroin is also an opioid. Some opioids are made from the opium plant, and others are synthetic (man-made).
Narcotic (Opioid) Drugs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Narcotic (Opioid) Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Pain Relief Application and Anesthesia Application are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Narcotic (Opioid) Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Narcotic (Opioid) Drugs key companies include Pfizer, Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, Collegium, Johnson & Johnson, Merck and Mylan, etc. Pfizer, Teva, Purdue Pharma are top 3 players and held % share in total in 2022.
Narcotic (Opioid) Drugs can be divided into Codeine, Fentanyl, Hydrocodone and Hydromorphone, etc. Codeine is the mainstream product in the market, accounting for % share globally in 2022.
Narcotic (Opioid) Drugs is widely used in various fields, such as Pain Relief Application and Anesthesia Application, etc. Pain Relief Application provides greatest supports to the Narcotic (Opioid) Drugs industry development. In 2022, global % share of Narcotic (Opioid) Drugs went into Pain Relief Application filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Narcotic (Opioid) Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Pfizer
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
Johnson & Johnson
Merck
Mylan
Hikma Pharmaceuticals
Sun Pharma
Endo Pharmaceuticals
Allergan
Segment by Type
Codeine
Fentanyl
Hydrocodone
Hydromorphone
Meperidine
Methadone
Others

Segment by Application


Pain Relief Application
Anesthesia Application
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Narcotic (Opioid) Drugs market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Narcotic (Opioid) Drugs introduction, etc. Narcotic (Opioid) Drugs Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Narcotic (Opioid) Drugs market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Narcotic (Opioid) Drugs
1.1 Narcotic (Opioid) Drugs Market Overview
1.1.1 Narcotic (Opioid) Drugs Product Scope
1.1.2 Narcotic (Opioid) Drugs Market Status and Outlook
1.2 Global Narcotic (Opioid) Drugs Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Narcotic (Opioid) Drugs Market Size by Region (2024-2034)
1.4 Global Narcotic (Opioid) Drugs Historic Market Size by Region (2024-2024)
1.5 Global Narcotic (Opioid) Drugs Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Narcotic (Opioid) Drugs Market Size (2024-2034)
1.6.1 North America Narcotic (Opioid) Drugs Market Size (2024-2034)
1.6.2 Europe Narcotic (Opioid) Drugs Market Size (2024-2034)
1.6.3 Asia-Pacific Narcotic (Opioid) Drugs Market Size (2024-2034)
1.6.4 Latin America Narcotic (Opioid) Drugs Market Size (2024-2034)
1.6.5 Middle East & Africa Narcotic (Opioid) Drugs Market Size (2024-2034)
2 Narcotic (Opioid) Drugs Market by Type
2.1 Introduction
2.1.1 Codeine
2.1.2 Fentanyl
2.1.3 Hydrocodone
2.1.4 Hydromorphone
2.1.5 Meperidine
2.1.6 Methadone
2.1.7 Others
2.2 Global Narcotic (Opioid) Drugs Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Narcotic (Opioid) Drugs Historic Market Size by Type (2024-2024)
2.2.2 Global Narcotic (Opioid) Drugs Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Narcotic (Opioid) Drugs Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Narcotic (Opioid) Drugs Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Narcotic (Opioid) Drugs Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Narcotic (Opioid) Drugs Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Narcotic (Opioid) Drugs Revenue Breakdown by Type (2024-2034)
3 Narcotic (Opioid) Drugs Market Overview by Application
3.1 Introduction
3.1.1 Pain Relief Application
3.1.2 Anesthesia Application
3.2 Global Narcotic (Opioid) Drugs Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Narcotic (Opioid) Drugs Historic Market Size by Application (2024-2024)
3.2.2 Global Narcotic (Opioid) Drugs Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Narcotic (Opioid) Drugs Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Narcotic (Opioid) Drugs Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Narcotic (Opioid) Drugs Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Narcotic (Opioid) Drugs Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Narcotic (Opioid) Drugs Revenue Breakdown by Application (2024-2034)
4 Narcotic (Opioid) Drugs Competition Analysis by Players
4.1 Global Narcotic (Opioid) Drugs Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Narcotic (Opioid) Drugs as of 2022)
4.3 Date of Key Players Enter into Narcotic (Opioid) Drugs Market
4.4 Global Top Players Narcotic (Opioid) Drugs Headquarters and Area Served
4.5 Key Players Narcotic (Opioid) Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Narcotic (Opioid) Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Narcotic (Opioid) Drugs Products, Services and Solutions
5.1.4 Pfizer Narcotic (Opioid) Drugs Revenue (US$ Million) & (2024-2024)
5.1.5 Pfizer Recent Developments
5.2 Teva
5.2.1 Teva Profile
5.2.2 Teva Main Business
5.2.3 Teva Narcotic (Opioid) Drugs Products, Services and Solutions
5.2.4 Teva Narcotic (Opioid) Drugs Revenue (US$ Million) & (2024-2024)
5.2.5 Teva Recent Developments
5.3 Purdue Pharma
5.3.1 Purdue Pharma Profile
5.3.2 Purdue Pharma Main Business
5.3.3 Purdue Pharma Narcotic (Opioid) Drugs Products, Services and Solutions
5.3.4 Purdue Pharma Narcotic (Opioid) Drugs Revenue (US$ Million) & (2024-2024)
5.3.5 Mallinckrodt Recent Developments
5.4 Mallinckrodt
5.4.1 Mallinckrodt Profile
5.4.2 Mallinckrodt Main Business
5.4.3 Mallinckrodt Narcotic (Opioid) Drugs Products, Services and Solutions
5.4.4 Mallinckrodt Narcotic (Opioid) Drugs Revenue (US$ Million) & (2024-2024)
5.4.5 Mallinckrodt Recent Developments
5.5 Amneal Pharma
5.5.1 Amneal Pharma Profile
5.5.2 Amneal Pharma Main Business
5.5.3 Amneal Pharma Narcotic (Opioid) Drugs Products, Services and Solutions
5.5.4 Amneal Pharma Narcotic (Opioid) Drugs Revenue (US$ Million) & (2024-2024)
5.5.5 Amneal Pharma Recent Developments
5.6 Collegium
5.6.1 Collegium Profile
5.6.2 Collegium Main Business
5.6.3 Collegium Narcotic (Opioid) Drugs Products, Services and Solutions
5.6.4 Collegium Narcotic (Opioid) Drugs Revenue (US$ Million) & (2024-2024)
5.6.5 Collegium Recent Developments
5.7 Johnson & Johnson
5.7.1 Johnson & Johnson Profile
5.7.2 Johnson & Johnson Main Business
5.7.3 Johnson & Johnson Narcotic (Opioid) Drugs Products, Services and Solutions
5.7.4 Johnson & Johnson Narcotic (Opioid) Drugs Revenue (US$ Million) & (2024-2024)
5.7.5 Johnson & Johnson Recent Developments
5.8 Merck
5.8.1 Merck Profile
5.8.2 Merck Main Business
5.8.3 Merck Narcotic (Opioid) Drugs Products, Services and Solutions
5.8.4 Merck Narcotic (Opioid) Drugs Revenue (US$ Million) & (2024-2024)
5.8.5 Merck Recent Developments
5.9 Mylan
5.9.1 Mylan Profile
5.9.2 Mylan Main Business
5.9.3 Mylan Narcotic (Opioid) Drugs Products, Services and Solutions
5.9.4 Mylan Narcotic (Opioid) Drugs Revenue (US$ Million) & (2024-2024)
5.9.5 Mylan Recent Developments
5.10 Hikma Pharmaceuticals
5.10.1 Hikma Pharmaceuticals Profile
5.10.2 Hikma Pharmaceuticals Main Business
5.10.3 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Products, Services and Solutions
5.10.4 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Revenue (US$ Million) & (2024-2024)
5.10.5 Hikma Pharmaceuticals Recent Developments
5.11 Sun Pharma
5.11.1 Sun Pharma Profile
5.11.2 Sun Pharma Main Business
5.11.3 Sun Pharma Narcotic (Opioid) Drugs Products, Services and Solutions
5.11.4 Sun Pharma Narcotic (Opioid) Drugs Revenue (US$ Million) & (2024-2024)
5.11.5 Sun Pharma Recent Developments
5.12 Endo Pharmaceuticals
5.12.1 Endo Pharmaceuticals Profile
5.12.2 Endo Pharmaceuticals Main Business
5.12.3 Endo Pharmaceuticals Narcotic (Opioid) Drugs Products, Services and Solutions
5.12.4 Endo Pharmaceuticals Narcotic (Opioid) Drugs Revenue (US$ Million) & (2024-2024)
5.12.5 Endo Pharmaceuticals Recent Developments
5.13 Allergan
5.13.1 Allergan Profile
5.13.2 Allergan Main Business
5.13.3 Allergan Narcotic (Opioid) Drugs Products, Services and Solutions
5.13.4 Allergan Narcotic (Opioid) Drugs Revenue (US$ Million) & (2024-2024)
5.13.5 Allergan Recent Developments
6 North America
6.1 North America Narcotic (Opioid) Drugs Market Size by Country (2024-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Narcotic (Opioid) Drugs Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Narcotic (Opioid) Drugs Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Narcotic (Opioid) Drugs Market Dynamics
11.1 Narcotic (Opioid) Drugs Industry Trends
11.2 Narcotic (Opioid) Drugs Market Drivers
11.3 Narcotic (Opioid) Drugs Market Challenges
11.4 Narcotic (Opioid) Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Narcotic (Opioid) Drugs Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Narcotic (Opioid) Drugs Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Narcotic (Opioid) Drugs Market Size Share by Region (2024-2024)
Table 4. Global Narcotic (Opioid) Drugs Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Narcotic (Opioid) Drugs Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Narcotic (Opioid) Drugs Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Narcotic (Opioid) Drugs Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Narcotic (Opioid) Drugs Revenue Market Share by Type (2024-2024)
Table 9. Global Narcotic (Opioid) Drugs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Narcotic (Opioid) Drugs Revenue Market Share by Type (2024-2034)
Table 11. North America Narcotic (Opioid) Drugs Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Narcotic (Opioid) Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Narcotic (Opioid) Drugs Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Narcotic (Opioid) Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Narcotic (Opioid) Drugs Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Narcotic (Opioid) Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Narcotic (Opioid) Drugs Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Narcotic (Opioid) Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Narcotic (Opioid) Drugs Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Narcotic (Opioid) Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Narcotic (Opioid) Drugs Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Narcotic (Opioid) Drugs Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Narcotic (Opioid) Drugs Revenue Market Share by Application (2024-2024)
Table 24. Global Narcotic (Opioid) Drugs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Narcotic (Opioid) Drugs Revenue Market Share by Application (2024-2034)
Table 26. North America Narcotic (Opioid) Drugs Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Narcotic (Opioid) Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Narcotic (Opioid) Drugs Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Narcotic (Opioid) Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Narcotic (Opioid) Drugs Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Narcotic (Opioid) Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Narcotic (Opioid) Drugs Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Narcotic (Opioid) Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Narcotic (Opioid) Drugs Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Narcotic (Opioid) Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Narcotic (Opioid) Drugs Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Narcotic (Opioid) Drugs Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Narcotic (Opioid) Drugs as of 2022)
Table 39. Date of Key Players Enter into Narcotic (Opioid) Drugs Market
Table 40. Global Narcotic (Opioid) Drugs Key Players Headquarters and Area Served
Table 41. Narcotic (Opioid) Drugs Product Solution and Service
Table 42. Global Narcotic (Opioid) Drugs Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Pfizer Basic Information List
Table 45. Pfizer Description and Business Overview
Table 46. Pfizer Narcotic (Opioid) Drugs Products, Services and Solutions
Table 47. Revenue (US$ Million) in Narcotic (Opioid) Drugs Business of Pfizer (2024-2024)
Table 48. Pfizer Recent Developments
Table 49. Teva Basic Information List
Table 50. Teva Description and Business Overview
Table 51. Teva Narcotic (Opioid) Drugs Products, Services and Solutions
Table 52. Revenue (US$ Million) in Narcotic (Opioid) Drugs Business of Teva (2024-2024)
Table 53. Teva Recent Developments
Table 54. Purdue Pharma Basic Information List
Table 55. Purdue Pharma Description and Business Overview
Table 56. Purdue Pharma Narcotic (Opioid) Drugs Products, Services and Solutions
Table 57. Revenue (US$ Million) in Narcotic (Opioid) Drugs Business of Purdue Pharma (2024-2024)
Table 58. Purdue Pharma Recent Developments
Table 59. Mallinckrodt Basic Information List
Table 60. Mallinckrodt Description and Business Overview
Table 61. Mallinckrodt Narcotic (Opioid) Drugs Products, Services and Solutions
Table 62. Revenue (US$ Million) in Narcotic (Opioid) Drugs Business of Mallinckrodt (2024-2024)
Table 63. Mallinckrodt Recent Developments
Table 64. Amneal Pharma Basic Information List
Table 65. Amneal Pharma Description and Business Overview
Table 66. Amneal Pharma Narcotic (Opioid) Drugs Products, Services and Solutions
Table 67. Revenue (US$ Million) in Narcotic (Opioid) Drugs Business of Amneal Pharma (2024-2024)
Table 68. Amneal Pharma Recent Developments
Table 69. Collegium Basic Information List
Table 70. Collegium Description and Business Overview
Table 71. Collegium Narcotic (Opioid) Drugs Products, Services and Solutions
Table 72. Revenue (US$ Million) in Narcotic (Opioid) Drugs Business of Collegium (2024-2024)
Table 73. Collegium Recent Developments
Table 74. Johnson & Johnson Basic Information List
Table 75. Johnson & Johnson Description and Business Overview
Table 76. Johnson & Johnson Narcotic (Opioid) Drugs Products, Services and Solutions
Table 77. Revenue (US$ Million) in Narcotic (Opioid) Drugs Business of Johnson & Johnson (2024-2024)
Table 78. Johnson & Johnson Recent Developments
Table 79. Merck Basic Information List
Table 80. Merck Description and Business Overview
Table 81. Merck Narcotic (Opioid) Drugs Products, Services and Solutions
Table 82. Revenue (US$ Million) in Narcotic (Opioid) Drugs Business of Merck (2024-2024)
Table 83. Merck Recent Developments
Table 84. Mylan Basic Information List
Table 85. Mylan Description and Business Overview
Table 86. Mylan Narcotic (Opioid) Drugs Products, Services and Solutions
Table 87. Revenue (US$ Million) in Narcotic (Opioid) Drugs Business of Mylan (2024-2024)
Table 88. Mylan Recent Developments
Table 89. Hikma Pharmaceuticals Basic Information List
Table 90. Hikma Pharmaceuticals Description and Business Overview
Table 91. Hikma Pharmaceuticals Narcotic (Opioid) Drugs Products, Services and Solutions
Table 92. Revenue (US$ Million) in Narcotic (Opioid) Drugs Business of Hikma Pharmaceuticals (2024-2024)
Table 93. Hikma Pharmaceuticals Recent Developments
Table 94. Sun Pharma Basic Information List
Table 95. Sun Pharma Description and Business Overview
Table 96. Sun Pharma Narcotic (Opioid) Drugs Products, Services and Solutions
Table 97. Revenue (US$ Million) in Narcotic (Opioid) Drugs Business of Sun Pharma (2024-2024)
Table 98. Sun Pharma Recent Developments
Table 99. Endo Pharmaceuticals Basic Information List
Table 100. Endo Pharmaceuticals Description and Business Overview
Table 101. Endo Pharmaceuticals Narcotic (Opioid) Drugs Products, Services and Solutions
Table 102. Revenue (US$ Million) in Narcotic (Opioid) Drugs Business of Endo Pharmaceuticals (2024-2024)
Table 103. Endo Pharmaceuticals Recent Developments
Table 104. Allergan Basic Information List
Table 105. Allergan Description and Business Overview
Table 106. Allergan Narcotic (Opioid) Drugs Products, Services and Solutions
Table 107. Revenue (US$ Million) in Narcotic (Opioid) Drugs Business of Allergan (2024-2024)
Table 108. Allergan Recent Developments
Table 109. North America Narcotic (Opioid) Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 110. North America Narcotic (Opioid) Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 111. Europe Narcotic (Opioid) Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 112. Europe Narcotic (Opioid) Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 113. Asia-Pacific Narcotic (Opioid) Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 114. Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region (2024-2024) & (US$ Million)
Table 115. Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region (2024-2034) & (US$ Million)
Table 116. Asia-Pacific Narcotic (Opioid) Drugs Market Share by Region (2024-2024)
Table 117. Asia-Pacific Narcotic (Opioid) Drugs Market Share by Region (2024-2034)
Table 118. Latin America Narcotic (Opioid) Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 119. Latin America Narcotic (Opioid) Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 120. Latin America Narcotic (Opioid) Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 121. Middle East & Africa Narcotic (Opioid) Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 122. Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 123. Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 124. Narcotic (Opioid) Drugs Market Trends
Table 125. Narcotic (Opioid) Drugs Market Drivers
Table 126. Narcotic (Opioid) Drugs Market Challenges
Table 127. Narcotic (Opioid) Drugs Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Narcotic (Opioid) Drugs Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Narcotic (Opioid) Drugs Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Narcotic (Opioid) Drugs Market Share by Regions: 2022 VS 2034
Figure 4. Global Narcotic (Opioid) Drugs Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Narcotic (Opioid) Drugs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Narcotic (Opioid) Drugs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Narcotic (Opioid) Drugs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Narcotic (Opioid) Drugs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Narcotic (Opioid) Drugs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Codeine
Figure 11. Global Codeine Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Fentanyl
Figure 13. Global Fentanyl Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Hydrocodone
Figure 15. Global Hydrocodone Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Product Picture of Hydromorphone
Figure 17. Global Hydromorphone Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 18. Product Picture of Meperidine
Figure 19. Global Meperidine Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 20. Product Picture of Methadone
Figure 21. Global Methadone Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 22. Product Picture of Others
Figure 23. Global Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Global Narcotic (Opioid) Drugs Market Size Share by Type: 2022 & 2034
Figure 25. North America Narcotic (Opioid) Drugs Revenue Market Share by Type (2024-2034)
Figure 26. Europe Narcotic (Opioid) Drugs Revenue Market Share by Type (2024-2034)
Figure 27. Asia-Pacific Narcotic (Opioid) Drugs Revenue Market Share by Type (2024-2034)
Figure 28. Latin America Narcotic (Opioid) Drugs Revenue Market Share by Type (2024-2034)
Figure 29. Middle East and Africa Narcotic (Opioid) Drugs Revenue Market Share by Type (2024-2034)
Figure 30. Pain Relief Application Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 31. Anesthesia Application Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 32. Global Narcotic (Opioid) Drugs Market Size Share by Application: 2022 & 2034
Figure 33. North America Narcotic (Opioid) Drugs Revenue Market Share by Application (2024-2034)
Figure 34. Europe Narcotic (Opioid) Drugs Revenue Market Share by Application (2024-2034)
Figure 35. Asia-Pacific Narcotic (Opioid) Drugs Revenue Market Share by Application (2024-2034)
Figure 36. Latin America Narcotic (Opioid) Drugs Revenue Market Share by Application (2024-2034)
Figure 37. Middle East and Africa Narcotic (Opioid) Drugs Revenue Market Share by Application (2024-2034)
Figure 38. Narcotic (Opioid) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 39. Global Top 5 and Top 10 Players Narcotic (Opioid) Drugs Market Share in 2022
Figure 40. North America Narcotic (Opioid) Drugs Market Share by Country (2024-2034)
Figure 41. United States Narcotic (Opioid) Drugs Market Size (2024-2034) & (US$ Million)
Figure 42. Canada Narcotic (Opioid) Drugs Market Size (2024-2034) & (US$ Million)
Figure 43. Germany Narcotic (Opioid) Drugs Market Size (2024-2034) & (US$ Million)
Figure 44. France Narcotic (Opioid) Drugs Market Size (2024-2034) & (US$ Million)
Figure 45. U.K. Narcotic (Opioid) Drugs Market Size (2024-2034) & (US$ Million)
Figure 46. Italy Narcotic (Opioid) Drugs Market Size (2024-2034) & (US$ Million)
Figure 47. Russia Narcotic (Opioid) Drugs Market Size (2024-2034) & (US$ Million)
Figure 48. Nordic Countries Narcotic (Opioid) Drugs Market Size (2024-2034) & (US$ Million)
Figure 49. Asia-Pacific Narcotic (Opioid) Drugs Market Share by Region (2024-2034)
Figure 50. China Narcotic (Opioid) Drugs Market Size (2024-2034) & (US$ Million)
Figure 51. Japan Narcotic (Opioid) Drugs Market Size (2024-2034) & (US$ Million)
Figure 52. South Korea Narcotic (Opioid) Drugs Market Size (2024-2034) & (US$ Million)
Figure 53. Southeast Asia Narcotic (Opioid) Drugs Market Size (2024-2034) & (US$ Million)
Figure 54. India Narcotic (Opioid) Drugs Market Size (2024-2034) & (US$ Million)
Figure 55. Australia Narcotic (Opioid) Drugs Market Size (2024-2034) & (US$ Million)
Figure 56. Latin America Narcotic (Opioid) Drugs Market Share by Country (2024-2034)
Figure 57. Mexico Narcotic (Opioid) Drugs Market Size (2024-2034) & (US$ Million)
Figure 58. Brazil Narcotic (Opioid) Drugs Market Size (2024-2034) & (US$ Million)
Figure 59. Middle East & Africa Narcotic (Opioid) Drugs Market Share by Country (2024-2034)
Figure 60. Turkey Narcotic (Opioid) Drugs Market Size (2024-2034) & (US$ Million)
Figure 61. Saudi Arabia Narcotic (Opioid) Drugs Market Size (2024-2034) & (US$ Million)
Figure 62. UAE Narcotic (Opioid) Drugs Market Size (2024-2034) & (US$ Million)
Figure 63. Bottom-up and Top-down Approaches for This Report